590006 Stock Overview
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Amrutanjan Health Care Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹648.60 |
52 Week High | ₹774.75 |
52 Week Low | ₹556.05 |
Beta | 0.71 |
1 Month Change | 7.64% |
3 Month Change | 8.96% |
1 Year Change | 3.97% |
3 Year Change | 4.45% |
5 Year Change | 114.02% |
Change since IPO | 5,486.56% |
Recent News & Updates
Recent updates
Shareholder Returns
590006 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -3.4% | -2.2% | -2.1% |
1Y | 4.0% | 55.3% | 45.3% |
Return vs Industry: 590006 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 590006 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
590006 volatility | |
---|---|
590006 Average Weekly Movement | 4.3% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 590006 has not had significant price volatility in the past 3 months.
Volatility Over Time: 590006's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1893 | 537 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays.
Amrutanjan Health Care Limited Fundamentals Summary
590006 fundamental statistics | |
---|---|
Market cap | ₹18.75b |
Earnings (TTM) | ₹440.09m |
Revenue (TTM) | ₹3.95b |
42.6x
P/E Ratio4.8x
P/S RatioIs 590006 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
590006 income statement (TTM) | |
---|---|
Revenue | ₹3.95b |
Cost of Revenue | ₹2.05b |
Gross Profit | ₹1.90b |
Other Expenses | ₹1.46b |
Earnings | ₹440.09m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 15.22 |
Gross Margin | 48.15% |
Net Profit Margin | 11.15% |
Debt/Equity Ratio | 0.3% |
How did 590006 perform over the long term?
See historical performance and comparison